Table 1

 Distribution of BRCAl founder mutations in cancer cases and controls (number (%))

C61G4153delA5382insCTotal
Breast15 (0.7%)1 (0.05%)43 (2.1%)59 (2.9%)
Ovarian13 (3.6%)8 (2.2%)28 (7.7%)49 (13.5%)
Controls1 (0.05%)1 (0.05%)4 (0.2%)6 (0.3%)